F&C Asset Management’s Edwards Lifesciences EW Stock Holding History

F&C Asset Management’s Portfolio EW Stock Details EW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2014 Q1	$557K	Buy	45,054 +690	+2%	+$7.96K	0.01%	634
2013 Q4	$486K	Sell	44,364 -3,600	-8%	-$40.6K	0.01%	655
2013 Q3	$557K	Sell	47,964 -11,718	-20%	-$137K	0.01%	637
2013 Q2	$668K	Buy	+59,682	New	+$706K	0.01%	612

Other funds holding EW

Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return

Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fairpointe Capital Chicago, Illinois $66.3M AUM 101.32% 1-Year Est. Return

BIT

BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return

GIM

Generation Investment Management London, United Kingdom $11.2B AUM 0.58% 1-Year Est. Return

BFA

BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return

F&C Asset Management's EW Position: Q1 2014 in Review

F&C Asset Management increased its Edwards Lifesciences (EW) stake by 1.6% in Q1 2014, buying an estimated $7.96K and bringing the position to 45,054 shares worth $557K. The position accounts for 0.01% of the portfolio, ranked #634.

F&C Asset Management first reported a position in EW in Q2 2013 and has held it in 4 quarters since. The position peaked at $668K in Q2 2013. 409 funds tracked by Wall St. Rank hold EW as of Q1 2014.

F&C Asset Management held 45,054 shares of Edwards Lifesciences worth $557K as of Q1 2014.
F&C Asset Management bought 690 Edwards Lifesciences shares in Q1 2014, an estimated $7.96K.
Edwards Lifesciences made up 0.01% of F&C Asset Management's portfolio in Q1 2014, its #634 holding.
F&C Asset Management first reported a position in Edwards Lifesciences in Q2 2013 and has held it in 4 quarters since.
F&C Asset Management's Edwards Lifesciences position peaked at $668K in Q2 2013.
409 funds tracked by Wall St. Rank held Edwards Lifesciences as of Q1 2014.

Based on F&C Asset Management's 13F filing for Q1 2014, filed 14 May 2014.